Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TROGLITAZONE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 394 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zinman, B
      PPAR gamma agonists in type 2 diabetes: how far have we come in 'preventing the inevitable'? A review of the metabolic effects of rosiglitazone

      DIABETES OBESITY & METABOLISM
    2. Moghetti, P
      Advances in the treatment of polycystic ovary syndrome

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    3. Kaplan, F; Al-Majali, K; Betteridge, DJ
      PPARs, insulin resistance and type 2 diabetes

      JOURNAL OF CARDIOVASCULAR RISK
    4. Scheen, AJ
      Thiazolidinediones and liver toxicity

      DIABETES & METABOLISM
    5. Bringer, J; Raingeard, I; Renard, E; Grigorescu, F; Lefebvre, P
      Insulin sensitivity and polycystic ovarian syndrome

      DIABETES & METABOLISM
    6. Reaven, GM
      Insulin resistance: why is it important to treat?

      DIABETES & METABOLISM
    7. Blickle, JF
      Thiazolidinediones: clinical data and perspectives

      DIABETES & METABOLISM
    8. Halimi, S
      Type 2 diabetes mellitus: Which place for thiazolidinediones in the therapeutic strategy?

      DIABETES & METABOLISM
    9. Peters, AL
      Using thiazolidinediones: Rosiglitazone and pioglitazone in clinical practice

      AMERICAN JOURNAL OF MANAGED CARE
    10. Inoue, M; Itoh, H; Tanaka, T; Chun, TH; Doi, K; Fukunaga, Y; Sawada, N; Yamshita, J; Masatsugu, K; Saito, T; Sakaguchi, S; Sone, M; Yamahara, K; Yurugi, T; Nakao, K
      Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    11. de Dios, ST; Hannan, KM; Dilley, RJ; Hill, MA; Little, PJ
      Troglitazone, but not rosiglitazone, inhibits Na/H exchange activity and proliferation of macrovascular endothelial cells

      JOURNAL OF DIABETES AND ITS COMPLICATIONS
    12. Glueck, CJ; Wang, P; Fontaine, R; Tracy, T; Sieve-Smith, L
      Metformin to restore normal menses in oligo-amenorrheic teenage girls withpolycystic ovary syndrome (PCOS)

      JOURNAL OF ADOLESCENT HEALTH
    13. Rovin, BH; Lu, L; Cosio, A
      Cyclopentenone prostaglandins inhibit cytokine-induced NF-kappa B activation and chemokine production by human mesangial cells

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    14. Grinspoon, S
      Insulin resistance in the HIV-lipodystrophy syndrome

      TRENDS IN ENDOCRINOLOGY AND METABOLISM
    15. Muto, S; Miyata, Y; Imai, M; Asano, Y
      Troglitazone stimulates basolateral rheogenic Na+/HCO3- cotransport activity in rabbit proximal straight tubules

      EXPERIMENTAL NEPHROLOGY
    16. Moore, KJ; Fitzgerald, ML; Freeman, MW
      Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?

      CURRENT OPINION IN LIPIDOLOGY
    17. Rosenblatt, S; Miskin, B; Glazer, NB; Prince, MJ; Robertson, KE
      The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus

      CORONARY ARTERY DISEASE
    18. Levine, RA; Sobel, BE
      Insulinoma, type 2 diabetes and plasminogen activator inhibitor type-I

      CORONARY ARTERY DISEASE
    19. Gouni-Berthold, I; Berthold, HK; Weber, AA; Seul, C; Vetter, H; Sachinidis, A
      Troglitazone and rosiglitazone inhibit the low density lipoprotein-inducedvascular smooth muscle cell growth

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    20. Chen, CC; Wang, HJ; Shih, HC; Sheen, LY; Chang, CT; Chen, RH; Wang, TY
      Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats

      JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    21. Sugawara, A; Takeuchi, K; Uruno, A; Ikeda, Y; Arima, S; Sato, K; Kudo, M; Taniyama, Y; Ito, S
      Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor genes

      Hypertension research
    22. Mohan, IK; Das, UN
      Prevention of chemically induced diabetes mellitus in experimental animalsby polyunsaturated fatty acids

      NUTRITION
    23. Holstad, M; Sandler, S
      A transcriptional inhibitor of TNF-alpha prevents diabetes induced by multiple low-dose streptozotocin injections in mice

      JOURNAL OF AUTOIMMUNITY
    24. Smith, U; Gogg, S; Johansson, A; Olausson, T; Rotter, V; Svalstedt, B
      Thiazolidinediones (PPAR gamma agonists) but not PPAR alpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes

      FASEB JOURNAL
    25. Chvojkova, S; Kazdova, L; Divisova, J
      A comparison of the effects of troglitazone and vitamin E on the fatty acid composition of serum phospholipids in an experimental model of insulin resistance

      PHYSIOLOGICAL RESEARCH
    26. Lestavel, S; Chinetti, G; Bocher, V; Fruchart, JC; Clavey, V; Staels, B
      Peroxisome proliferator-activated receptors in human atherosclerosis

      M S-MEDECINE SCIENCES
    27. Grimaldi, A; Hartemann-Heurtier, A
      Type 2 diabetes mellitus: choosing the right therapeutic strategy

      PRESSE MEDICALE
    28. Lehtovirta, M; Forsen, B; Gullstrom, M; Haggblom, M; Eriksson, JG; Taskinen, MR; Groop, L
      Metabolic effects of metformin in patients with impaired glucose tolerance

      DIABETIC MEDICINE
    29. Nicolaides, E; Symillides, M; Dressman, JB; Reppas, C
      Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration

      PHARMACEUTICAL RESEARCH
    30. Zhang, B; Shiomi, M; Tanaka, H; Mei, J; Fan, P; Tsujita, Y; Horikoshi, H; Saku, K
      Effects of high-dose troglitazone on insulin sensitivity and beta-cell function in watanabe heritable hyperlipidemic rabbits

      EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    31. Guan, YF; Zhang, YH; Schneider, A; Davis, L; Breyer, RM; Breyer, MD
      Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature

      AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
    32. Haskins, JR; Rowse, P; Rahbari, R; de la Iglesia, FA
      Thiazolidinedione toxicity to isolated hepatocytes revealed by coherent multiprobe fluorescence microscopy and correlated with multiparameter flow cytometry of peripheral leukocytes

      ARCHIVES OF TOXICOLOGY
    33. Farrar, NS; Chambers, NJ; Carlsson, AR; Denyer, G; Johnston, GAR
      Effect of a series of novel sulphonylthioureas on glucose tolerance in theobese fa/fa Zucker rat

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    34. Mu, YM; Yanase, T; Nishi, Y; Takayanagi, R; Goto, K; Nawata, H
      Combined treatment with specific ligands for PPAR gamma : RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    35. Toprak, S; Yonem, A; Cakir, B; Guler, S; Azal, O; Ozata, M; Corakci, A
      Insulin resistance in nonobese patients with polycystic ovary syndrome

      HORMONE RESEARCH
    36. Vander Lugt, JT; Gomez-Marquez, J; Caldon, J; Louters, LL
      Combined effects of troglitazone and muscle contraction on insulin sensitization in Balb-c mouse muscle

      BIOCHIMIE
    37. Funk, C; Pantze, M; Jehle, L; Ponelle, C; Scheuermann, G; Lazendic, M; Gasser, R
      Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate

      TOXICOLOGY
    38. St Peter, JV; Neafus, KL; Khan, MA; Vessey, JT; Lockheart, MSK
      Factors associated with the risk of liver enzyme elevation in patients with type 2 diabetes treated with a thiazolidinedione

      PHARMACOTHERAPY
    39. Bissell, DM; Gores, GJ; Laskin, DL; Hoofnagle, JH
      Drug-induced liver injury: Mechanisms and test systems

      HEPATOLOGY
    40. Ng, EHY; Wat, NMS; Ho, PC
      Effects of metformin on ovulation rate, hormonal and metabolic profiles inwomen with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial

      HUMAN REPRODUCTION
    41. Marino, G; Lewis, JH
      Drug-induced liver disease

      CURRENT OPINION IN GASTROENTEROLOGY
    42. Pedraza, N; Solanes, G; Iglesias, R; Vazquez, M; Giralt, M; Villarroya, F
      Differential regulation of expression of genes encoding uncoupling proteins 2 and 3 in brown adipose tissue during lactation in mice

      BIOCHEMICAL JOURNAL
    43. Yoshida, K; Kohzuki, M; Xu, HL; Wu, XM; Kamimoto, M; Sato, T
      Effects of troglitazone and temocapril in spontaneously hypertensive rats with chronic renal failure

      JOURNAL OF HYPERTENSION
    44. Harrigan, RA; Nathan, MS; Beattie, P
      Oral agents for the treatment of type 2 diabetes mellitus: Pharmacology, toxicity, and treatment

      ANNALS OF EMERGENCY MEDICINE
    45. Nicholas, SB; Kawano, Y; Wakino, S; Collins, AR; Hsueh, WA
      Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells

      HYPERTENSION
    46. Cowan, SM; Bunch, SE
      Oral antidiabetic drugs for cats

      COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN
    47. Hupfeld, CJ; Weiss, RH
      TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    48. Tornvig, L; Mosekilde, L; Justesen, J; Falk, E; Kassem, M
      Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice

      CALCIFIED TISSUE INTERNATIONAL
    49. Bedoucha, M; Atzpodien, E; Boelsterli, UA
      Diabetic KKA(y) mice exhibit increased hepatic PPAR gamma 1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones

      JOURNAL OF HEPATOLOGY
    50. Nakamura, T; Funahashi, T; Yamashita, S; Nishida, M; Nishida, Y; Takahashi, M; Hotta, K; Kuriyama, H; Kihara, S; Ohuchi, N; Nishimura, T; Kishino, B; Ishikawa, K; Kawamoto, T; Tokunaga, K; Nakagawa, C; Mineo, I; Watanabe, F; Tarui, S; Matsuzawa, Y
      Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation - double-blind placebo-controlled trial

      DIABETES RESEARCH AND CLINICAL PRACTICE
    51. Maruyama, S; Yanagisawa, K; Kanamuro, R; Teno, S; Iwamoto, Y
      Serum leptin level as an indicator to predict the clinical efficacy of troglitazone in patients with type 2 diabetes mellitus

      DIABETES RESEARCH AND CLINICAL PRACTICE
    52. Hirayama, H; Sugano, M; Abe, N; Yonemoch, H; Makino, N
      Troglitazone, an antidiabetic drug, improves left ventricular mass and diastolic function in nonmotensive diabetic patients

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    53. Niino, M; Iwabuchi, K; Kikuchi, S; Ato, M; Morohashi, T; Ogata, A; Tashiro, K; Onoe, K
      Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma

      JOURNAL OF NEUROIMMUNOLOGY
    54. Caldwell, SH; Hespenheide, ER; Von Borstel, RW
      Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simavastatin

      DIGESTIVE DISEASES AND SCIENCES
    55. Yokoyama, I; Yonekura, K; Moritan, T; Tateno, M; Momose, T; Ohtomo, K; Inoue, Y; Nagai, R
      Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients

      JOURNAL OF NUCLEAR MEDICINE
    56. Tsuji, T; Mizushige, K; Noma, T; Murakami, K; Ohmori, K; Miyatake, A; Kohno, M
      Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type II diabetic rat

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    57. Raskin, P; Rendell, M; Riddle, MC; Dole, JF; Freed, MI; Rosenstock, J
      A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes

      DIABETES CARE
    58. Miyazaki, Y; Mahankali, A; Matsuda, M; Glass, L; Mahankali, S; Ferrannini, E; Cusi, K; Mandarino, LJ; DeFronzo, RA
      Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone

      DIABETES CARE
    59. Phillips, LS; Grunberger, G; Miller, E; Patwardhan, R; Rappaport, EB; Salzman, A
      Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes

      DIABETES CARE
    60. Katsuki, A; Sumida, Y; Gabazza, EC; Murashima, S; Furuta, M; Araki-Sasaki, R; Hori, Y; Yano, Y; Adachi, Y
      Homeostasis model assessment is a reliable indicator of insulin resistanceduring follow-up of patients with type 2 diabetes

      DIABETES CARE
    61. Hsueh, WA; Jackson, S; Law, RE
      Control of vascular cell proliferation and migration by PPAR-gamma - A newapproach to the macrovascular complications of diabetes

      DIABETES CARE
    62. Gale, EAM
      Lessons from the glitazones: a story of drug development

      LANCET
    63. Kaplowitz, N
      Drug-induced liver disorders - Implications for drug development and regulation

      DRUG SAFETY
    64. Inglis, AML; Miller, AK; Culkin, KT; Finnerty, D; Patterson, SD; Jorkasky, DK; Freed, MI
      Lack of effect of rosiglitazone on the pharmacokinetics of oral contraceptives in healthy female volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    65. Lebovitz, HE; Banerji, MA
      Insulin resistance and its treatment by thiazolidinediones

      RECENT PROGRESS IN HORMONE RESEARCH, VOL 56
    66. Sekiya, M; Suzuki, J; Watanabe, K; Funada, J; Otani, T; Akutsu, H
      Beneficial effect of troglitazone, an insulin-sensitizing antidiabetic agent, on coronary circulation in patients with non-insulin-dependent diabetesmellitus

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    67. Masuzaki, H; Paterson, J; Shinyama, H; Morton, NM; Mullins, JJ; Seckl, JR; Flier, JS
      A transgenic model of visceral obesity and the metabolic syndrome

      SCIENCE
    68. Ito, M; Yamamoto, K; Sato, H; Fujiyama, Y; Bamba, T
      Inhibitory effect of troglitazone on glucuronidation catalyzed by human uridine diphosphate-glucuronosyltransferase 1A6

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    69. Kubota, K; Kawabe, E; Hinotsu, S; Hamada, C; Ohashi, Y; Kurokawa, K
      Pilot study of prescription-event monitoring in Japan comparing troglitazone with alternative oral hypoglycemics

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    70. Gouni-Berthold, I; Berthold, HK; Weber, AA; Ko, Y; Seul, C; Vetter, H; Sachinidis, A
      Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    71. Igarashi, M; Hirata, A; Yamaguchi, H; Tsuchiya, H; Ohnuma, H; Tominaga, M; Daimon, M; Kato, T
      Characterization of an inhibitory effect of pioglitazone on balloon-injured vascular smooth muscle cell growth

      METABOLISM-CLINICAL AND EXPERIMENTAL
    72. Ebeling, P; Teppo, AM; Koistinen, HA; Koivisto, VA
      Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes

      METABOLISM-CLINICAL AND EXPERIMENTAL
    73. Suzuki, Y; Urano, T; Ihara, H; Nakajima, T; Nagai, N; Takada, Y; Taminato, T; Takada, A
      Bezafibrate attenuates the overexpression of plasminogen activator inhibitor-1 messenger RNA by a combination of mono-unsaturated fatty acid and insulin in HepG2 cells

      LIFE SCIENCES
    74. Toyoda, Y; Tsuchida, A; Iwami, E; Miwa, I
      Toxic effect of troglitazone on cultured rat hepatocytes

      LIFE SCIENCES
    75. Koshiyama, H; Shimono, D; Kuwamura, N; Minamikawa, J; Nakamura, Y
      Inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    76. Azziz, R; Ehrmann, D; Legro, RS; Whitcomb, RW; Hanley, R; Fereshetian, AG; O'Keefe, M; Ghazzi, MN
      Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    77. Lebovitz, HE; Dole, JF; Patwardhan, R; Rappaport, EB; Freed, MI
      Rosiglitazone monotherapy is effective in patients with type 2 diabetes

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    78. Kim, JH; Lewin, TM; Coleman, RA
      Expression and characterization of recombinant rat acyl-CoA synthetases 1,4, and 5 - Selective inhibition by triacsin C and thiazolidinediones

      JOURNAL OF BIOLOGICAL CHEMISTRY
    79. Arlt, W; Auchus, RJ; Miller, WL
      Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3 beta-hydroxysteroid dehydrogenase

      JOURNAL OF BIOLOGICAL CHEMISTRY
    80. Fukunaga, Y; Itoh, H; Doi, K; Tanaka, T; Yamashita, J; Chun, TH; Inoue, M; Masatsugu, K; Sawada, N; Saito, T; Hosoda, K; Kook, H; Ueda, M; Nakao, K
      Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides

      ATHEROSCLEROSIS
    81. Janka, HU
      Glitazone - Profile of a new class of substances

      INTERNIST
    82. Itami, A; Watanabe, G; Shimada, Y; Hashimoto, Y; Kawamura, J; Kato, M; Hosotani, R; Imamura, M
      Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo

      INTERNATIONAL JOURNAL OF CANCER
    83. Schneider, MB; Matsuzaki, H; Haorah, J; Ulrich, A; Standop, J; Ding, XZ; Adrian, TE; Pour, PM
      Prevention of pancreatic cancer induction in hamsters by metformin

      GASTROENTEROLOGY
    84. Vandermolen, DT; Ratts, VS; Evans, WS; Stovall, DW; Kauma, SW; Nestler, JE
      Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

      FERTILITY AND STERILITY
    85. Naderali, EK; Pickavance, LC; Wilding, JPH; Doyle, PJ; Wiliams, G
      Troglitazone corrects metabolic changes but not vascular dysfunction in dietary-obese rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    86. Camp, HS; Chaudhry, A; Leff, T
      A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes

      ENDOCRINOLOGY
    87. Way, JM; Harrington, WW; Brown, KK; Gottschalk, WK; Sundseth, SS; Mansfield, TA; Ramachandran, RK; Willson, TM; Kliewer, SA
      Comprehensive messenger ribonucleic acid profiling reveals that peroxisomeproliferator-activated receptor gamma activation has coordinate effects ongene expression in multiple insulin-sensitive tissues

      ENDOCRINOLOGY
    88. Komar, CM; Braissant, O; Wahli, W; Curry, TE
      Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period

      ENDOCRINOLOGY
    89. Corpe, C; Sreenan, S; Burant, C
      Effects of type-2 diabetes and troglitazone on the expression patterns of small intestinal sugar transporters and PPAR-gamma in the Zucker diabetic fatty rat

      DIGESTION
    90. Cha, BS; Ciaraldi, TP; Carter, L; Nikoulina, SE; Mudaliar, S; Mukherjee, R; Paterniti, JR; Henry, RR
      Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle

      DIABETOLOGIA
    91. Rosenstock, M; Greenberg, AS; Rudich, A
      Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-alpha in 3T3-L1 adipocytes

      DIABETOLOGIA
    92. de Souza, CJ; Eckhardt, M; Gagen, K; Dong, M; Chen, W; Laurent, D; Burkey, BF
      Effects of pioglitazone on adipose tissue remodeling within the setting ofobesity and insulin resistance

      DIABETES
    93. Brunmair, B; Gras, F; Neschen, S; Roden, M; Wagner, L; Waldhausl, W; Furnsinn, C
      Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression

      DIABETES
    94. Yue, TL; Chen, J; Bao, WK; Narayanan, PK; Bril, A; Jiang, W; Lysko, PG; Gu, JL; Boyce, R; Zimmerman, DM; Hart, TK; Buckingham, RE; Ohlstein, EH
      In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

      CIRCULATION
    95. Yamamoto, K; Ohki, R; Lee, RT; Ikeda, U; Shimada, K
      Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes

      CIRCULATION
    96. Sobel, BE
      Acceleration of restenosis by diabetes - Pathogenetic implications

      CIRCULATION
    97. Ulrich, RG; Bacon, JA; Brass, EP; Cramer, CT; Petrella, DK; Sun, EL
      Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon

      CHEMICO-BIOLOGICAL INTERACTIONS
    98. Palakurthi, SS; Aktas, H; Grubissich, LM; Mortensen, RM; Halperin, JA
      Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation

      CANCER RESEARCH
    99. Furuse, Y; Ogino, K; Shimoyama, M; Sasaki, N; Hisatome, I
      Ca2+-sensitizing effect is involved in the positive inotropic effect of troglitazone

      BRITISH JOURNAL OF PHARMACOLOGY
    100. Davies, GF; Khandelwal, RL; Wu, LY; Juurlink, BHJ; Roesler, WJ
      Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression bytroglitazone: a peroxisome proliferator-activated receptor-gamma (PPAR gamma)-independent, antioxidant-related mechanism

      BIOCHEMICAL PHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 20:41:22